The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study

References

• World Health OrganizationThe top 10 causes of death2017 Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed July 12, 2017
   Google Scholar
• HsiaoAJChenLHLuTHTen leading causes of death in Taiwan: a comparison of two grouping listsJ Formos Med Assoc2015114867968024457066
   PubMed Web of Science ®Google Scholar
• TsaiYHYangTMLinCMHuangSYWenYWTrends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010Int J Chron Obstruct Pulmon Dis2017122787279329026296
   PubMed Web of Science ®Google Scholar
• BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax200863540240718234906
   PubMed Web of Science ®Google Scholar
• MakeBDutroMPPaulose-RamRMartonJPMapelDWUnder-treatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
   PubMed Web of Science ®Google Scholar
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: revised 20112011 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Jan21.pdf
   Google Scholar
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary DiseaseReport. 20172017 Available from: http://goldcopd.org/gold2017-global-strategy-diagnosis-management-prevention-copdAccessed March 25, 2018
   Google Scholar
• ArkhipovVArkhipovaDMiravitllesMLazarevAStukalinaECharacteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trialInt J Chron Obstruct Pulmon Dis2017123255326229138554
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• SharifRCuevasCRWangYAroraMSharmaGGuideline adherence in management of stable chronic obstructive pulmonary diseaseRespir Med201310771046105223639271
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• HanMKMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPD Gene: a prospective cohort studyLancet Respir Med201311435024321803
   PubMed Web of Science ®Google Scholar
• HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
   PubMed Web of Science ®Google Scholar
• SorianoJBAlfagemeIAlmagroPDistribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationChest2013143369470223187891
   PubMed Web of Science ®Google Scholar
• SunLChenYWuRLuMYaoWChanges in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in ChinaInt J Chron Obstruct Pulmon Dis2017123095310229118578
   PubMed Web of Science ®Google Scholar
• Cabrera LópezCCasanova MacarioCMarín TrigoJMComparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on grouping and outcomesAm J Respir Crit Care Med2018197446346929099607
   PubMed Web of Science ®Google Scholar
• Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Guidelines of COPD Management: 2012 revision2012
   Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• OhYMBhomeABBoonsawatWCharacteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian citiesInt J Chron Obstruct Pulmon Dis20138313923378753
   PubMed Web of Science ®Google Scholar
• BarnesPJTheophyllineAm J Respir Crit Care Med2013188890190623672674
   PubMed Web of Science ®Google Scholar
• SehlJO’DohertyJO’ConnorRO’SullivanBO’ReganAAdherence to COPD management guidelines in general practice? A review of the literatureIr J Med Sci2018187240340728735500
   PubMed Web of Science ®Google Scholar
• SenEGucluSZKibarIAdherence to GOLD guideline treatment recommendations among pulmonologists in TurkeyInt J Chron Obstruct Pulmon Dis2015102657266326715844
   PubMed Web of Science ®Google Scholar
• VisentinENieriDVagagginiBPeruzziEPaggiaroPAn observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014Curr Med Res Opin20163291493150227215310
   PubMed Web of Science ®Google Scholar
• LiFCaiYZhuYThe evaluation of general practitioners’ awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburbAsia Pac J Public Health2015272NP2067NP207823420058
   PubMed Web of Science ®Google Scholar
• MiravitllesMde La RozaCNaberanKLambanMGobarttEMartinAUse of spirometry and patterns of prescribing in COPD in primary careRespir Med200710181753176017448651
   PubMed Web of Science ®Google Scholar
• LucasASmeenkFSmeeleIBrouwerTvan SchayckOThe validity of diagnostic support of an asthma/COPD service in primary careBr J Gen Pract20075754489289617976290
   PubMed Web of Science ®Google Scholar
• JonesRCDickson-SpillmannMMatherMJMarksDShackellBSAccuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care auditRespir Res200896218710575
   PubMed Web of Science ®Google Scholar
• BourbeauJSebaldtRJDayAPractice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE studyCan Respir J2008151131918292848
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
   PubMed Web of Science ®Google Scholar
• WoutersEFPostmaDSFokkensBWithdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trialThorax200560648048715923248
   PubMed Web of Science ®Google Scholar
• ChoudhuryABDawsonCMKilvingtonHEWithdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trialRespir Res200789318162137
   PubMed Web of Science ®Google Scholar
• CasciniSKirchmayerUBelleudiVInhaled corticosteroid use in chronic obstructive pulmonary disease and risk of pneumonia: a nested case-control population-based study in Lazio (Italy) – The OUTPUL StudyCOPD201714331131728406337
   PubMedGoogle Scholar
• DisantostefanoRLSampsonTLeHVHindsDDavisKJBakerlyNDRisk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort studyPLoS One201495e9714924878543
   PubMed Web of Science ®Google Scholar
• YawnBPLiYTianHZhangJArconaSKahlerKHInhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysisInt J Chron Obstruct Pulmon Dis2013829530423836970
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
   PubMed Web of Science ®Google Scholar
• JiangYQZhuYXChenXLImpact of adherence to GOLD guidelines on 6-minute walk distance, MRC dyspnea scale score, lung function decline, quality of life, and quality-adjusted life years in a Shanghai suburbGenet Mol Res20151438861887026345817
   PubMed Web of Science ®Google Scholar
• PerezXWisniveskyJPLurslurchachaiLKleinmanLCKronishIMBarriers to adherence to COPD guidelines among primary care providersRespir Med2012106337438122000501
   PubMed Web of Science ®Google Scholar